October 1st Deadline: Employers Must Provide Notice to Employees of Health Insurance Exchange Options
Model employee notices can be accessed at www.dol.gov. (updated link)
Source
Source
National Government Services Upcoming Webinars on Chiropractic Services
This past month in the United Kingdom, physical therapists gained the right to prescribe medications independently.
Filmmaker and NCLC guest speaker Jeff Hayes is in the process of putting the finishing touches on his latest documentary, "Medical Inc." The film examines the history surrounding the American Medical Association's conspiracy against the chiropractic profession--which ultimately led to the Wilk vs. AMA trial--and dissects the current medical monopoly and its efforts to suppress complementary and alternative care. With more than 80 interviews conducted and first-hand accounts from people of various backgrounds and professions, this film is certain to shed new light on how important chiropractic services are to the health and well-being of the public. To see a sneak preview of the film and learn how you can play an active role in the anticipated September release of this documentary.
The American Chiropractic Association (ACA) mourns the loss of its Chairman of the Board of Governors (BOG) Robert Mastronardi, DC, 60, who passed away yesterday following a battle with cancer.
The American Chiropractic Association (ACA) hosted its annual meeting in Newport, RI September 30-October 2, 2010. The 2010 ACA Alternate Delegate of the Year was awarded to Louis Lupinacci, DC, FICC. Dr. Lupinacci is the ACA NY Downstate Alternate Delegate and current NYSCA Vice President. Accepting the award on behalf of Dr. Lupinacci was Dr. H. William Wolfson ACA NY Downstate Delegate. Dr. Wolfson acknowledged Dr. Lupinacci’s service to the ACA, “Mild mannered, bright, even tempered, kind, professional, gentleman are only a few of the words you can use to describe this respected, admired and loved doctor … He is deserving of this prestigious ACA award and honor”. Dr. Wolfson added how appropriate it was for Dr. Lupinacci to receive this award in Rhode Island, as Dr. Lupinacci was born here! NYSCA extends our best wishes to Dr. Lupinacci on this well deserved award and the ACA by recognizing Dr. Lupinacci for his service to the profession, its doctors and patients!
"We ain't one-at-a-timin' here. We're MASS communicating!'" - Pappy O'Daniel
If you think of Facebook as a place for high schoolers and soccer moms, think again. Facebook has quickly earned a following of over 500,000,000 fanatical users who tune in early and often every day. Moreover, as of March 2010, Facebook surpassed Google in daily pageviews. However, that alone is not the reason to make Facebook a part of your chiropractic online advertising strategy.
EVERYONE KNOWS WHEN YOU "LIKE" SOMEONE
Until now, when a new patient found you via Google, Yahoo, Bing, Dogpile, or NYSCA.com, how many friends could you assume they'd tell about your site. Answer: zero. They might make it a bookmark or favorite but probably did not tell anyone else about your site at least not until after their first appointment. THIS IS WHERE FACEBOOK CHANGES THE MARKETING GAME.
HOW does Facebook spread the word virally?
The two-year randomised clinical trial is the largest to study the effect of B vitamins on mild cognitive impairment, and one of the first disease-modifying trials in the Alzheimer’s field to show positive results in people.
Around 1 in 6 elderly people over the age of 70 has mild cognitive impairment, experiencing problems with memory, language, or other mental functions, but not to a degree that interferes with daily life. Around half of people with mild cognitive impairment go on to develop dementia – mainly Alzheimer’s disease – within five years of diagnosis.
Certain B vitamins – folic acid, vitamin B6 and vitamin B12 – are known to control levels of the amino acid homocysteine in the blood, and high levels of homocysteine are associated with an increased risk of Alzheimer’s.
So the Oxford team set out to see whether supplements of the B vitamins that lower homocysteine could slow the higher rate of brain shrinkage, or atrophy, observed in mild cognitive impairment or Alzheimer’s.
The study followed 168 volunteers aged 70 or over with mild memory problems, half of whom took high dose B vitamin tablets for two years and the other half a placebo tablet. The researchers assessed disease progression in this group by using MRI scans to measure the brain atrophy rate over a two-year period. The findings are published in the journal PLoS ONE.
The team found that on average the brains of those taking the folic acid, vitamin B6 and B12 treatment shrank at a rate of 0.76% a year, while those in the placebo group had a mean brain shrinkage rate of 1.08%. People with the highest levels of homocysteine benefited most, showing atrophy rates on treatment that were half of those on placebo.
Along with rate of brain shrinkage, the team from the Oxford Project to Investigate Memory and Ageing (OPTIMA) also monitored cognitive test scores, revealing that those with the slowest rate of shrinkage scored more strongly.
The team suggests that, since the rate of brain atrophy is known to be more rapid in those with mild cognitive impairment who go on to develop Alzheimer’s, it is possible that the vitamin treatment could slow down the development of the disease. Clinical trials to test this should now be carried out, they add.
‘It is our hope that this simple and safe treatment will delay the development of Alzheimer’s disease in many people who suffer from mild memory problems,’ said Professor David Smith of the Department of Pharmacology at Oxford University, a co-leader of the trial. ‘Today there are about 1.5 million elderly in UK, 5 million in USA and 14 million in Europe with such memory problems.
‘These are immensely promising results but we do need to do more trials to conclude whether these particular B vitamins can slow or prevent development of Alzheimer’s. So I wouldn’t yet recommend that anyone getting a bit older and beginning to be worried about memory lapses should rush out and buy vitamin B supplements without seeing a doctor,’ he said.
Rebecca Wood, Chief Executive of the Alzheimer’s Research Trust, which co-funded the study, said: ‘These are very important results, with B vitamins now showing a prospect of protecting some people from Alzheimer’s in old age. The strong findings must inspire an expanded trial to follow people expected to develop Alzheimer’s, and we hope for further success.
‘We desperately need to support research into dementia, to help avoid the massive increases of people living with the condition as the population ages. Research is the only answer to what remains the greatest medical challenge of our time.’
Professor Chris Kennard, chair of the Medical Research Council’s Neurosciences and Mental Health Board which co-funded the study, said: ‘This MRC-funded trial brings us a step closer to unravelling the complex neurobiology of ageing and cognitive decline, which holds the key to the development of future treatments for conditions like Alzheimer’s disease. The findings are very encouraging and we look forward to further research that is needed in order to test whether B vitamins can be recommended as a suitable treatment.’
On Friday, the FTC issued a notice indicating that the Red Flags Rule would not be enforced until January 1, 2011. Over the past few months Congress has been debating whether this regulation should apply to healthcare providers. The AMA has also filed a lawsuit against the FTC because they believe that the FTC has overstepped its bounds by attempting to apply this regulation to healthcare providers. In the next few months I believe we will see a bill passed which would exempt healthcare providers from this regulation.
For more information on the Red Flags Rule visit: www.acatoday.org/redflags. Read the FTC’s release here.
Greeley, Colo.— Paul D. Townsend, D.C., the NBCE Director of Practical Testing Research and Development , is the lead author on an article published in the January 2010 issue of the journal Teaching and Learning in Medicine. NBCE Director of Testing and Executive Vice President Mark G. Christensen also contributed to the article.
ABSTRACT Background: Red yeast rice is an herbal supplement that decreases low-density lipoprotein (LDL) cholesterol level. Objective: To evaluate the effectiveness and tolerability of red yeast rice and therapeutic lifestyle change to treat dyslipidemia in patients who cannot tolerate statin therapy. Design: Randomized, controlled trial. Setting: Community-based cardiology practice. Patients: 62 patients with dyslipidemia and history of discontinuation of statin therapy due to myalgias. Intervention: Patients were assigned by random allocation software to receive red yeast rice, 1800 mg (31 patients), or placebo (31 patients) twice daily for 24 weeks. All patients were concomitantly enrolled in a 12-week therapeutic lifestyle change program. Measurements: Primary outcome was LDL cholesterol level, measured at baseline, week 12, and week 24. Secondary outcomes included total cholesterol, high-density lipoprotein (HDL) cholesterol, triglyceride, liver enzyme, and creatinine phosphokinase (CPK) levels; weight; and Brief Pain Inventory score. Results: In the red yeast rice group, LDL cholesterol decreased by 1.11 mmol/L (43 mg/dL) from baseline at week 12 and by 0.90 mmol/L (35 mg/dL) at week 24. In the placebo group, LDL cholesterol decreased by 0.28 mmol/L (11 mg/dL) at week 12 and by 0.39 mmol/L (15 mg/dL) at week 24. Low-density lipoprotein cholesterol level was significantly lower in the red yeast rice group than in the placebo group at both weeks 12 (P < 0.001) and 24 (P = 0.011). Significant treatment effects were also observed for total cholesterol level at weeks 12 (P < 0.001) and 24 (P = 0.016). Levels of HDL cholesterol, triglyceride, liver enzyme, or CPK; weight loss; and pain severity scores did not significantly differ between groups at either week 12 or week 24. Limitation: The study was small, was single-site, was of short duration, and focused on laboratory measures. Conclusion: Red yeast rice and therapeutic lifestyle change decrease LDL cholesterol level without increasing CPK or pain levels and may be a treatment option for dyslipidemic patients who cannot tolerate statin therapy. Annals of Internal Medicine 16 June 2009 Volume 150 Issue 12 Pages 830-839
Abstract Background: Reduced intake of micronutrients during pregnancy exposes women to nutritional deficiencies and may affect fetal growth. We conducted a systematic review to examine the efficacy of prenatal supplementation with multimicronutrients on pregnancy outcomes. Methods: We searched MEDLINE, EMBASE, CINAHL and the Cochrane Library for relevant articles published in English up to December 2008. We also searched the bibliographies of selected articles as well as clinical trial registries. The primary outcome was low birth weight; secondary outcomes were preterm birth, small-for-gestational-age infants, birth weight and gestational age. Results: We observed a significant reduction in the risk of low birth weight among infants born to women who received multimicronutrients during pregnancy compared with placebo (relative risk [RR] 0.81, 95% confidence interval [CI] 0.73–0.91) or iron–folic acid supplementation (RR 0.83, 95% CI 0.74–0.93). Birth weight was significantly higher among infants whose mothers were in the multimicronutrient group than among those whose mothers received iron–folic acid supplementation (weighted mean difference 54 g, 95% CI 36 g–72 g). There was no significant differences in the risk of preterm birth or small-for-gestational-age infants between the 3 study groups. Interpretation: Prenatal multimicronutrient supplementation was associated with a significantly reduced risk of low birth weight and with improved birth weight when compared with iron–folic acid supplementation. There was no significant effect of multimicronutrient supplementation on the risk of preterm birth or small-for-gestational-age infants. CMAJ • June 9, 2009; 180 (12). doi:10.1503/cmaj.081777.
The New York State Chiropractic Association asks members to support the ACA chiropractic advocacy network, ChiroVoice.org (ChiroVoice). Through this chiropractic advocacy network, patients and chiropractic supporters can stay informed about important health care issues and contact their legislators in Washington. Chiropractic supporters will be able to educate policymakers about the value of chiropractic and work to positively impact any legislative efforts to reform the current national health care system. ChiroVoice will also enable the NYSCA to mobilize patient support at the state level for legislative action when necessary. Ask your patients to sign up now! (Please be sure to adhere to all HIPAA regulations if signing patients up in your office.) The time is now for ChiroVoice! The opportunity to challenge some of the long standing issues beleaguering our profession. Prevention... Wellness... Fee Parity....Anti Discrimination Statutes, Full Scope Medicare, etc. These are just a few of our issues to be debated in DC. Historically, when given the chance to compete on a level playing field our profession shines. Along the same lines, historically the way we get there is through grass roots activities. The ACA has iniated ChiroVoice. Yet, many docs have not asked patients and staff to sign up. Please take time today to get your patients and staff involved. The Senate is marking up legislation this week and the House in a few weeks. President Obama wants a bill on his desk by the fall if not sooner. We can shape our future. It is said "Inaction has as significant of an impact as action," please don't let inaction cause us to fail. It's up to all of us to get involved, be involved, stay involved and be triumphant...we all benefit! Thanks for your help! Louis Lupinacci, DC, FICC NYSCA Vice President H. William Wolfson, DC, FICC NYS Downstate Delegate
Greeley, Colo.—On May 7, two directors of the National Board of Chiropractic Examiners (NBCE), were honored by the Federation of Chiropractic Licensing Boards (FCLB) who bestowed upon them the 2009 George R. Arvidson Award for Meritorious Service. This award is the highest individual honor presented annually at the FCLB annual meeting. NBCE President Dr. Vernon R. Temple was honored by the FCLB for his exceptional leadership, innovation and service to chiropractic. Dr. Temple was first elected to serve the National Board as District III director in the year 2000. Since then, Dr. Temple has also served on the NBCE Executive Committee as secretary and vice president. He was elected as president of the board in 2007 and will continue in that role until May 2010. Dr. Temple is a graduate of Palmer College of Chiropractic in Davenport, Iowa, and has been in practice in Vermont since 1978. He is a diplomate of the American Board of Chiropractic Orthopedists. He is a former chairman of the Federation of Chiropractic Licensing Boards and has also served as president of the Vermont Board of Chiropractic Examination and Regulation. NBCE Director Dr. Oliver R. Smith, Jr., and outgoing president of the FCLB received an Arvidson Award for his work in financially stabilizing the FCLB and strengthening the organization’s focus. Dr. Smith previously served as president, vice president, treasurer, and District IV director of the FCLB. He served as and NBCE director from 2005-2009 and was elected as director-at-large on the NBCE board in May 2009. He is a past president of the Texas Board of Chiropractic Examiners and received the Keeler Plaque Award in 1997 as an outstanding chiropractic practitioner in Texas. Dr. Smith is a graduate of Texas Chiropractic College. Headquartered in Greeley, Colo., the NBCE is the international testing organization for the chiropractic profession. Established in 1963, the NBCE develops, administers and scores legally defensible, standardized written and practical examinations for candidates seeking chiropractic licensure throughout the United States and in many foreign countries.
GREELEY, Colo.—On May 8, the National Board of Chiropractic Examiners (NBCE) held its Annual Board Meeting in conjunction with the Federation of Chiropractic Licensing Boards’ (FCLB) 83rd Annual Educational Conference in Hollywood, CA. At the meeting, NBCE delegates elected Dr. Paul N. Morin (ME) as District III Director, replacing Dr. Mary-Ellen Rada (NJ). The delegates re-elected Dr. Norman E. Ouzts, Jr. (SC) as District V Director. Dr. Robin R. Lecy (SD), District I Director; Dr. Donna L. Craft (MI), District II Director; and Dr. Theodore J. Scott (UT), District IV Director will continue their terms. NBCE Directors-at-Large Dr. Vernon Temple (VT), and Dr. N. Edwin Weathersby (AZ) were re-elected to their at-large positions. Dr. Oliver Smith was elected as a new at-large director and NBCE Director-at-Large Dr. Richard L. Cole (TN) will continue his term. The two remaining positions on the 11-member NBCE Board of Directors are filled by the president and vice-president of the Federation of Chiropractic Licensing Boards: Dr. Daniel Saint-Germain (Quebec, Canada) and Dr. Lawrence O’Connor (NJ), respectively, were appointed to serve on the NBCE Board of Directors. The Executive Committee was then elected by the board. Dr. Vernon Temple was re-elected as President, Dr. N. Edwin Weathersby as Vice President and Dr. Theodore Scott as Treasurer. Dr. Richard L. Cole was elected to the Executive Committee as Secretary. Headquartered in Greeley, Colo., the NBCE is the international testing organization for the chiropractic profession. Established in 1963, the NBCE develops, administers and scores legally defensible, standardized written and practical examinations for candidates seeking chiropractic licensure throughout the United States and in many foreign countries.
The Virginia Chiropractic Association (VCA) and the Virginia Society of Chiropractic (VSC) announced their intent to unite into a single entity and the formation of a Unification Committee. The unification will create a single, more influential association in the Commonwealth of Virginia that will better serve chiropractic doctors, patients, and the profession as a whole. The goal is to reduce duplication, allowing the profession to devote more resources and expertise to public policy, education, legal and legislative initiatives. Over the past several years, the organizations have begun collaborating more and more frequently, assisting each other in legislative activities and conducting joint educational programs. Both presidents accepted honorary memberships in the other organizations and face-to-face meetings and conference calls between the two Boards and staff became regular occurrences. The Unification Committee is charged with fleshing out the myriad of organizational, operational, and legal details and considerations involved in bringing the two groups together. In addition, it will outline a plan to provide a framework for the rules that will govern the organizations during the consolidation period, thereby ensuring a smooth transition.
WASHINGTON, D.C. —During a conference call today with reporters, Senator John D. (Jay) Rockefeller IV (D-W.Va.), Chairman of the Senate Finance Subcommittee on Health Care, and Congressman Joe Courtney (D-Conn.), Member of the House Education and Labor Committee, announced the introduction of the Pre-existing Condition Patient Protection Act that would end insurance discrimination against those who live with pre-existing or chronic illness. “We have 133 million Americans living with chronic illness – insurance companies should no longer be allowed to reap profits by denying care to sick Americans,” said Senator Rockefeller. “We as a nation can no longer stand by and continue to allow this practice to occur. These medical services are not optional, and most times, they are not affordable without insurance. Our system is broken—which is why we must eliminate the ability of insurers to deny coverage for pre-existing conditions in every single market. The time for serious action is now.” “It is wrong and impractical to commit ourselves to health care reform without addressing the faulty and ill-advised pre-existing condition exclusion,” stated Congressman Courtney. “This discriminatory practice prevents millions of hardworking Americans from changing or finding new jobs and in this economy that is just plain wrong. Senator Rockefeller and I agree that it is time for the most advanced nation in the world to have a world-class health care system that is fair and affordable.” Background The Pre-existing Condition Patient Protection Act will eliminate pre-existing condition exclusions in all insurance markets, a major step forward for the 133 million Americans living with at least one chronic condition. Eliminating pre-existing condition exclusions is a priority of the Obama Administration and Senator Rockefeller and Congressman Courtney plan to work closely with President Obama to enact this vital legislation. Insurance market reform must be a central part of comprehensive health reform. Both Senator Rockefeller and Congressman Courtney believe that all individuals should have access to comprehensive, meaningful, and affordable health insurance coverage—and this legislation is a critical component of achieving that goal. Summary of the legislation ****The Pre-existing Condition Patient Protection Act is a bill to protect consumers excluded from receiving health insurance coverage due to a “pre-existing condition.” ****The Pre-existing Condition Patient Protection Act would require the Secretary of Health and Human Services to submit a report to Congress on the extent of adverse selection (i.e. which happens when less healthy people disproportionately enroll in a risk pool) that occurs because insurers can no longer exclude patients with pre-existing conditions. This report must include data from private insurers on the characteristics of their insured population. This new reporting requirement would provide transparency on the true mix of patients and patient claims experience among private insurers; and ****Require the Government Accountability Office to submit a report to Congress addressing the impact of this legislation on reducing the number of uninsured and underinsured, as well as its effect on the affordability of health insurance coverage. This is meant to highlight both the positive impact this new policy will have on making coverage more accessible for individuals with chronic conditions, but also recognize that without further regulatory changes, coverage may not be affordable for these individuals. ****The Pre-existing Condition Patient Protection Act of 2009 has been endorsed by twenty-two organizations, including: American Autoimmune Related Diseases Association; American Heart Association/American Stroke Association; Association of Black Cardiologists, Inc.; Association of Community Cancer Centers; Breast Cancer Network of Strength; Children’s Cause for Cancer Advocacy; Congenital Heart; Information Network; Dermatology Nurses’ Association; First Focus; International Myeloma Foundation; Lung Cancer Alliance; Lupus Foundation of America; Mended Little Hearts; National Association of Pediatric Nurse Practitioners; National Patient Advocate Foundation; Oncology Nursing Society; Ovarian Cancer National Alliance; Pediatric Stroke Network, Inc.; Sarcoma Foundation of America; Sudden Cardiac Arrest Association; The Leukemia & Lymphoma Society; and The Wellness Community.
Vitamin C Intake and the Risk of Gout in Men Abstract A Prospective Study Background Several metabolic studies and a recent double-blind, placebo-controlled, randomized trial have shown that higher vitamin C intake significantly reduces serum uric acid levels. Yet the relation with risk of gout is unknown. Methods We prospectively examined, from1986 through 2006, the relation between vitamin C intake and risk of incident gout in 46 994 male participants with no history of gout at baseline. We used a supplementary questionnaire to ascertain the American College of Rheumatology criteria for gout. Vitamin C intake was assessed every 4 years through validated questionnaires. Results During the 20 years of follow-up, we documented 1317 confirmed incident cases of gout. Compared with men with vitamin C intake less than 250 mg/d, the multivariate relative risk (RR) of gout was 0.83 (95% confidence interval [CI], 0.71-0.97) for total vitamin C intake of 500 to 999 mg/d, 0.66 (0.52-0.86) for 1000 to 1499 mg/d, and 0.55 (0.38-0.80) for 1500 mg/d or greater (P < .001 for trend). The multivariate RR per 500-mg increase in total daily vitamin C intake was 0.83 (95% CI, 0.77-0.90). Compared with men who did not use supplemental vitamin C, the multivariate RR of gout was 0.66 (95% CI, 0.49-0.88) for supplemental vitamin C intake of 1000 to 1499 mg/d and 0.55 (0.36-0.86) for 1500 mg/d or greater (P < .001 for trend). Conclusions Higher vitamin C intake is independently associated with a lower risk of gout. Supplemental vitamin C intake may be beneficial in the prevention of gout. Authors Affiliations: Division of Rheumatology, Department of Medicine, Arthritis Research Centre of Canada, Vancouver General Hospital, University of British Columbia, Vancouver, Canada (Dr Choi); Channing Laboratory (Drs Choi, Gao, and Curhan) and Renal Division, Department of Medicine (Dr Curhan), Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston (Drs Gao and Curhan). Dr Choi is now with the Rheumatology Section, Clinical Epidemiology Unit, Boston University School of Medicine, Boston. Arch Intern Med. 2009;169(5):502-507.
After carefully listening and reviewing member comments, the Foundation for Chiropractic Education and Research has opened its popular new DCConsult® website to all at no cost. The former subscription only site has been revamped, with a new emphasis on the needs of the practicing clinician. Driven by two major search engines anyone can now visit www.DCConsult.com and instantaneously run a search for the most current research abstracts. A click of a button and the site immediately translates from English to Spanish, French, German, Italian or Portuguese. For the past two years, it has been the goal of the FCER’s Board of Trustees to provide easy access for the profession to the literature, articles, links, educational products and more. DCConsult is now the globally recognized repository of such information. From South Africa, Evalie K. Heath, DC writes, “This is Wonderful news. A Very Big Thank you for your new policy to make DCConsult available to everyone at no cost. DCConsult will be a wonderful tool for ALL Chiropractors to access chiropractic articles, research and news. Those of us in more remote areas of the Earth (remote from Chiropractic schools and centers of research) and especially those in areas with economic difficulties greatly appreciate this decision.” Dr. Heath goes on to encourage colleagues in Uganda, South Africa, Nambia, Mozambique, Mauritius, Kenya, Ghana, Ethiopia, Congo: “Dear Africa Members, DCConsult opens the world of Chiropractic information to our very finger tips. Please enjoy this new privilege. Please inform all of your members and colleagues.” FCER’s President, Dr. Charles Herring stated, “As long as new research and articles emerge – DCConsult will never be finished. Information, as well as translations are being added as quickly as possible. The web site will continually change – so visit often.” FCER Vice President, Dr. Ronald Evans explains, "Moving DCConsult into the open access domain has not been without significant challenges. Newer site designs require more data to keep content current. FCER/DCConsult is seeking volunteer expertise to make the content more robust in several ways: 1) Contribution of original Evidence Based Medicine/Evidence Based Principles (EBM/EBP) material, 2) Abstract mining from any source germane to chiropractic science, 3) Book/Textbook recommendations for a website book list, and 4) Occasional chiropractic research consultancy. Never before in the 65-year history of this foundation has the need been greater for the chiropractic profession to step forward and assist with a project of this global magnitude." Coming soon is a FCER Member only section offering free audios, patient handouts and other downloads especially for those who financially support FCER activities. DCConsult would not be possible without the support of Standard Process Inc., National Board of Chiropractic Examiners, Future Health Inc., Academy of Chiropractic Orthopedists, American College of Chiropractic Consultants, College on Forensic Sciences and others. The Foundation for Chiropractic Education and Research celebrates its 65th Anniversary in 2009. FCER is a 501(c)3 not-for-profit foundation with a mission To promote the health and well being of humanity by encouraging and supporting research and education relative to the field of chiropractic care, and to provide information needed to document and improve chiropractic healthcare capacity worldwide. DCConsult directly aligns with FCER’s mission and is worthy of your support.